Viewing Study NCT06980532


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-02 @ 6:44 AM
Study NCT ID: NCT06980532
Status: RECRUITING
Last Update Posted: 2025-05-20
First Post: 2025-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer
Sponsor: Liu Huang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module